Gunnarsson O, Andersson S B, Johansson S A
Eur J Drug Metab Pharmacokinet. 1983 Oct-Dec;8(4):395-402. doi: 10.1007/BF03188772.
The hydrolysis of estramustine phosphate by enzymes of blood, liver, intestines and prostate of man, dog and rat was studied by using specific analytical methods for the parent compound and some of its metabolites. Estramustine phosphate was stable in blood and plasma of different species but rapidly dephosphorylated to estramustine by liver, intestinal and prostatic enzymes. The prostate was the most active tissue. The ester bond by which nornitrogen mustard is linked to estradiol-17-phosphate was slowly cleaved by enzymes from the liver and prostate of the rat, dog and man. The dog tissues were more effective than those of the rat and man. Intestinal enzymes also exhibited the ability to hydrolyze the carbamic ester, but to a greater extent in the rat than in the dog. It is concluded that, with regard to the metabolism of estramustine, the rat is more similar to man than is the dog. Possible clinical implications of the biotransformation of estramustine phosphate are discussed.
利用针对母体化合物及其某些代谢产物的特定分析方法,研究了人、狗和大鼠的血液、肝脏、肠道及前列腺中的酶对磷酸雌莫司汀的水解作用。磷酸雌莫司汀在不同物种的血液和血浆中稳定,但可被肝脏、肠道及前列腺中的酶迅速去磷酸化为雌莫司汀。前列腺是最活跃的组织。去甲氮芥与雌二醇 -17- 磷酸相连的酯键可被大鼠、狗和人的肝脏及前列腺中的酶缓慢裂解。狗的组织比大鼠和人的组织更有效。肠道酶也具有水解氨基甲酸酯的能力,但在大鼠中比在狗中更显著。结论是,就雌莫司汀的代谢而言,大鼠与人比与狗更相似。讨论了磷酸雌莫司汀生物转化可能的临床意义。